These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors. Sintchak MD; Nimmesgern E Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288 [TBL] [Abstract][Full Text] [Related]
3. Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes. Jain J; Almquist SJ; Ford PJ; Shlyakhter D; Wang Y; Nimmesgern E; Germann UA Biochem Pharmacol; 2004 Feb; 67(4):767-76. PubMed ID: 14757177 [TBL] [Abstract][Full Text] [Related]
4. Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors: a patent and scientific literature review (2002-2016). Cuny GD; Suebsuwong C; Ray SS Expert Opin Ther Pat; 2017 Jun; 27(6):677-690. PubMed ID: 28074661 [TBL] [Abstract][Full Text] [Related]
5. Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents. Shah CP; Kharkar PS Eur J Med Chem; 2018 Oct; 158():286-301. PubMed ID: 30223117 [TBL] [Abstract][Full Text] [Related]
6. Regulation of the interaction of inosine monophosphate dehydrogenase with mycophenolic Acid by GTP. Ji Y; Gu J; Makhov AM; Griffith JD; Mitchell BS J Biol Chem; 2006 Jan; 281(1):206-12. PubMed ID: 16243838 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives. Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342 [TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of human Molt-4 leukemia type II inosine 5'-monophosphate dehydrogenase by the 1,5-diazabicyclo[3.1.0]hexane-2,4-diones. Barnes BJ; Eakin AE; Izydore RA; Hall IH Biochemistry; 2000 Nov; 39(45):13641-50. PubMed ID: 11076502 [TBL] [Abstract][Full Text] [Related]
9. Inosine 5'-monophosphate dehydrogenase inhibitors for the treatment of autoimmune diseases. Ratcliffe AJ Curr Opin Drug Discov Devel; 2006 Sep; 9(5):595-605. PubMed ID: 17002220 [TBL] [Abstract][Full Text] [Related]
10. Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid. Digits JA; Hedstrom L Biochemistry; 1999 Nov; 38(46):15388-97. PubMed ID: 10563825 [TBL] [Abstract][Full Text] [Related]
11. A novel series of non-nucleoside inhibitors of inosine 5'-monophosphate dehydrogenase with immunosuppressive activity. Franklin TJ; Morris WP; Jacobs VN; Culbert EJ; Heys CA; Ward WH; Cook PN; Jung F; Plé P Biochem Pharmacol; 1999 Sep; 58(5):867-76. PubMed ID: 10449198 [TBL] [Abstract][Full Text] [Related]
12. Repurposing existing drugs: identification of irreversible IMPDH inhibitors by high-throughput screening. Sarwono AEY; Mitsuhashi S; Kabir MHB; Shigetomi K; Okada T; Ohsaka F; Otsuguro S; Maenaka K; Igarashi M; Kato K; Ubukata M J Enzyme Inhib Med Chem; 2019 Dec; 34(1):171-178. PubMed ID: 30451014 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding site. Prosise GL; Wu JZ; Luecke H J Biol Chem; 2002 Dec; 277(52):50654-9. PubMed ID: 12235158 [TBL] [Abstract][Full Text] [Related]
15. Inosine 5'-Monophosphate Dehydrogenase (IMPDH) as a Potential Target for the Development of a New Generation of Antiprotozoan Agents. Fotie J Mini Rev Med Chem; 2018; 18(8):656-671. PubMed ID: 27334467 [TBL] [Abstract][Full Text] [Related]
16. Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5'-monophosphate dehydrogenase inhibitor. Jain J; Almquist SJ; Heiser AD; Shlyakhter D; Leon E; Memmott C; Moody CS; Nimmesgern E; Decker C J Pharmacol Exp Ther; 2002 Sep; 302(3):1272-7. PubMed ID: 12183689 [TBL] [Abstract][Full Text] [Related]
17. Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation. Zimmermann AG; Gu JJ; Laliberté J; Mitchell BS Prog Nucleic Acid Res Mol Biol; 1998; 61():181-209. PubMed ID: 9752721 [TBL] [Abstract][Full Text] [Related]
18. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery. Nair V; Shu Q Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958 [TBL] [Abstract][Full Text] [Related]
19. A novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity. Makowska-Grzyska M; Kim Y; Maltseva N; Osipiuk J; Gu M; Zhang M; Mandapati K; Gollapalli DR; Gorla SK; Hedstrom L; Joachimiak A J Biol Chem; 2015 Feb; 290(9):5893-911. PubMed ID: 25572472 [TBL] [Abstract][Full Text] [Related]
20. [The determination and clinical application of inosine 5’-monophosphate dehydrogenase activity]. Liu FY; Qiu XY; Jiao Z Yao Xue Xue Bao; 2016 Nov; 51(11):1666-73. PubMed ID: 29908108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]